I'm looking for a job. I exported this list from FewerJobs.com - a curated job board.

Please:
1. Rank these jobs by fit for me, given my resume / skills.
2. Highlight the top 5 with a one-sentence rationale each.
3. Flag any concerns, including benefit values without source-backed evidence.
4. Suggest one or two filter changes I could make on FewerJobs to find more good matches.

Filters I applied:
- q: Tonix Pharmaceuticals Holding Corp
- quality_floor: all
- match_401k_strict: true
- parental_strict: true
- non_birth_strict: true
- pto_strict: true
- include_older: false
- apply_url_verified: false
- page: 1
- per_page: 100
- sort: relevance

Jobs (100 total):

---
TITLE: Scientist II, Animal Model Development
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: Frederick, MD (unspecified)
SALARY: $70K-$120K
POSTED: 2026-03-05
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4170744009
EXCERPT: Scientist II, Animal Model Development Frederick, MD Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix Research and Development Center
---
TITLE: Senior Specialist, Regulatory Operations
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: Frederick, MD (unspecified)
SALARY: $70K-$130K
POSTED: 2026-01-15
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4106035009
EXCERPT: Senior Specialist, Regulatory Operations Frederick, MD Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Senior Specialist, Regulatory Operations, will
---
TITLE: Postdoctoral Fellowship-Immunology
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: Frederick, MD 21701 (unspecified)
SALARY: $75K-$95K
POSTED: 2026-05-18
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4245264009
EXCERPT: Postdoctoral Fellowship-Immunology Frederick, MD 21701 Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix is seeking a highly motivated and
---
TITLE: Pharmacovigilance Scientist
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: Berkeley Heights, NJ (unspecified)
SALARY: $124K-$170K
POSTED: 2026-04-02
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4205666009
EXCERPT: Pharmacovigilance Scientist Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix is seeking an experienced Pharmacovigilance Scientist
---
TITLE: Thought Leader Liaison (TLL), West Region
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: United States (unspecified)
SALARY: $130K-$200K
POSTED: 2026-02-12
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4130652009
EXCERPT: Thought Leader Liaison (TLL), West Region United States Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Associate Director, Thought
---
TITLE: Associate Director, Regulatory Affairs
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: Berkeley Heights, NJ or Frederick, MD or North Dartmouth, MA or Fort Worth, TX (unspecified)
SALARY: $190K-$200K
POSTED: 2026-04-14
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4215536009
EXCERPT: Associate Director, Regulatory Affairs Berkeley Heights, NJ or Frederick, MD or North Dartmouth, MA or Fort Worth, TX Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property
---
TITLE: Sr. Director, Brand Marketing
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: Berkeley Heights, NJ (unspecified)
SALARY: $190K-$285K
POSTED: 2026-04-24
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4227536009
EXCERPT: Sr. Director, Brand Marketing Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Senior Director, Brand Marketing
---
TITLE: Senior Manager, Total Rewards
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: Berkeley Heights, NJ (unspecified)
SALARY: $130K-$170K
POSTED: 2026-05-05
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4239809009
EXCERPT: Senior Manager, Total Rewards Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Senior Manager, Total Rewards
---
TITLE: Manager, Corporate Strategy and CEO Initiatives
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: Berkeley Heights, NJ (unspecified)
SALARY: $90K-$150K
POSTED: 2026-06-04
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4272302009
EXCERPT: Manager, Corporate Strategy and CEO Initiatives Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Manager, Corporate
---
TITLE: Manager, Quality Systems & Administration
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: North Dartmouth, MA (unspecified)
SALARY: $110K-$145K
POSTED: 2026-04-13
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4214661009
EXCERPT: Manager, Quality Systems & Administration North Dartmouth, MA Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview: The Manager, Quality Systems
---
TITLE: Associate Scientist I, Immunology
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: Frederick, MD 21701 (unspecified)
SALARY: $50K-$70K
POSTED: 2026-05-18
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4245265009
EXCERPT: Associate Scientist I, Immunology Frederick, MD 21701 Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix is seeking an Associate
---
TITLE: Senior Manager, Cost Accounting
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: Berkeley Heights, NJ or Frederick, MD or North Dartmouth, MA (unspecified)
SALARY: $100K-$150K
POSTED: 2026-05-21
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4248421009
EXCERPT: Senior Manager, Cost Accounting Berkeley Heights, NJ or Frederick, MD or North Dartmouth, MA Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners.
---
TITLE: Senior Director of CMC and Nonclinical Program Management
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: North Dartmouth, MA (unspecified)
SALARY: $224K-$280K
POSTED: 2026-03-19
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4186570009
EXCERPT: Senior Director of CMC and Nonclinical Program Management North Dartmouth, MA Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix
---
TITLE: Manager, Trade & Market Access
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: Berkeley Heights, NJ (unspecified)
SALARY: $90K-$150K
POSTED: 2026-03-05
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4170833009
EXCERPT: Manager, Trade & Market Access Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Manager of Trade
---
TITLE: Director, Commercial Operations and Analytics
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: Berkeley Heights, NJ (unspecified)
SALARY: $180K-$230K
POSTED: 2025-12-15
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4077936009
EXCERPT: Director, Commercial Operations and Analytics Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Director, Commercial Operations
---
TITLE: VP, Clinical Development - Infectious Disease
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: Frederick, Maryland or Berkeley Heights, New Jersey (unspecified)
SALARY: $250K-$350K
POSTED: 2026-01-20
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4108447009
EXCERPT: VP, Clinical Development - Infectious Disease Frederick, Maryland or Berkeley Heights, New Jersey Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position
---
TITLE: Director, Regulatory Affairs - Infectious Disease
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: Berkeley Heights, NJ (unspecified)
SALARY: $150K-$240K
POSTED: 2026-03-11
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4180874009
EXCERPT: Director, Regulatory Affairs - Infectious Disease Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Director, Regulatory
---
TITLE: Director, Investor Relations
EMPLOYER: Amylyx Pharmaceuticals Inc
LOCATION: Cambridge, MA (unspecified)
SALARY: $204K-$230K
POSTED: 2026-05-26
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/amylyx/jobs/6002934004
EXCERPT: Director, Investor Relations Cambridge, MA Amylyx has an audacious mission to usher in a new era for treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitment to the communities we serve. We are a clinical-stage company currently focused on post-bariatric hypoglycemia (PBH), Wolfram syndrome, and amyotrophic lateral sclerosis (ALS). Our mission is powered by our people. Our core values - be audacious, be curious, be authentic, be engaged, and be accountable - creating a culture of caring. Amylyx has assembled an experienced team ready to take action because the communities we serve have no time to wait. If you share our passion and are determined to tackle some of medicine's toughest problems, we encourage you to read the opportunity below and apply. The Opportunity Join Amylyx at a pivotal moment of growth and visibility as our Director, Investor Relations -a high-impact role at the center of our corporate story, strategy, and market presence. In this position, you'll work side-by-side with the VP of Investor Relations & Communications and partner closely with our senior leadership team-including our co-CEOs, CFO, CMO, and CCO-to shape how the investment community understands and values our mission. You'll serve as a strategic advisor and storyteller, helping to translate complex science and financial performance into a clear, compelling narrative that resonates with investors and analysts. You'll play a key role in strengthening our investor engagement program, building meaningful relationships, and influencing how Amylyx
---
TITLE: Senior Vice President, Sales
EMPLOYER: Amylyx Pharmaceuticals Inc
LOCATION: Flexible/ U.S. Based (unspecified)
SALARY: $353K-$397K
POSTED: 2026-05-13
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/amylyx/jobs/5994725004
EXCERPT: Senior Vice President, Sales Flexible/ U.S. Based Amylyx has an audacious mission to usher in a new era for treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitment to the communities we serve. We are a clinical-stage company currently focused on post-bariatric hypoglycemia (PBH), Wolfram syndrome, and amyotrophic lateral sclerosis (ALS). Our mission is powered by our people. Our core values - be audacious, be curious, be authentic, be engaged, and be accountable - creating a culture of caring. Amylyx has assembled an experienced team ready to take action because the communities we serve have no time to wait. If you share our passion and are determined to tackle some of medicine's toughest problems, we encourage you to read the opportunity below and apply. The Opportunity The SVP of Sales will play a critical leadership role in building and executing the commercial strategy for a pre‑commercial biotechnology company preparing for its first product launch. This individual will be responsible for designing and implementing the Go‑To‑Market (GTM) strategy, recruiting and developing a high‑performing sales organization, establishing strong relationships with Key Opinion Leaders (KOLs), ensuring full sales force readiness ahead of launch and driving performance. We anticipate hiring the Senior Vice President, Sales in September 2026. The ideal candidate combines strategic vision with hands‑on execution experience in specialty pharma or biotech launches and thrives in a fast‑paced, build‑from‑scratch environment. Responsibilities Enterprise Commercial Leadership - Shape overall U.S. commercial
---
TITLE: Head of Pharmaceutical R&D PTDC-F
EMPLOYER: Roche Holding AG
LOCATION: Basel, Basel-City, Switzerland (unspecified)
SALARY: Not disclosed
POSTED: 2026-02-13
APPLY_URL: https://roche.wd3.myworkdayjobs.com/roche-ext/job/Basel/Head-of-Pharmaceutical-R-D-PTDC-F_202502-103969-1/apply
EXCERPT: Head of Pharmaceutical R&D PTDC-F Basel, Basel-City, Switzerland Join our team as the Head of Pharmaceutical R&D, where you will lead innovative drug development initiatives, ensuring regulatory compliance and driving scientific excellence. Collaborate with cross-functional teams to deliver impactful solutions that enhance patient care and advance healthcare globally.
---
TITLE: National Sales Director - Pharmaceuticals (Infectious Disease)
EMPLOYER: Asahi Kasei Corp.
LOCATION: Remote Home Office USA (remote)
SALARY: Not disclosed
POSTED: 2026-05-27
K401_MATCH: yes (not source-backed)
APPLY_URL: https://akamerica.wd501.myworkdayjobs.com/aka/job/Remote-Home-Office-USA/National-Sales-Director---Pharmaceuticals--Infectious-Disease-_R5586-1
EXCERPT: National Sales Director - Pharmaceuticals (Infectious Disease) Remote Home Office USA posted: Posted 16 Days Ago
---
TITLE: Associate Director, SEC Reporting & Technical Accounting
EMPLOYER: Vaxcyte Inc
LOCATION: San Carlos, California, United States (unspecified)
SALARY: $184K-$215K
POSTED: 2026-02-26
K401_MATCH: yes (not source-backed)
APPLY_URL: https://boards.greenhouse.io/vaxcyte/jobs/5126186008?gh_jid=5126186008
EXCERPT: Associate Director, SEC Reporting & Technical Accounting San Carlos, California, United States Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: The Associate Director, SEC Reporting & Technical Accounting will serve as a key contributor to the company's external reporting and technical accounting function. Reporting to the Senior Director, Technical Accounting & SEC Reporting, this role will be highly hands-on, owning the preparation and execution of SEC filings and technical
---
TITLE: Director, Financial Planning & Analysis, R&D
EMPLOYER: Vaxcyte Inc
LOCATION: San Carlos, California, United States (unspecified)
SALARY: $226K-$264K
POSTED: 2026-04-03
K401_MATCH: yes (not source-backed)
APPLY_URL: https://boards.greenhouse.io/vaxcyte/jobs/5173368008?gh_jid=5173368008
EXCERPT: Director, Financial Planning & Analysis, R&D San Carlos, California, United States Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: This is an exciting opportunity to serve as a strategic finance business partner to Vaxcyte's R&D organization, with a focus on clinical studies. The role will support Clinical Operations and the Immunoassay and Non-Clinical teams, with responsibility for clinical trial and serology financial oversight, while flexing to support broader R&D
---
TITLE: Director, National Accounts - Pharmaceuticals
EMPLOYER: Asahi Kasei Corp.
LOCATION: Remote Home Office USA (remote)
SALARY: Not disclosed
POSTED: 2026-05-12
K401_MATCH: yes (not source-backed)
APPLY_URL: https://akamerica.wd501.myworkdayjobs.com/aka/job/Remote-Home-Office-USA/Director--National-Accounts---Pharmaceuticals_R5545-1
EXCERPT: Director, National Accounts - Pharmaceuticals Remote Home Office USA posted: Posted 30+ Days Ago
---
TITLE: Manager, Pharmaceutical Sales Training
EMPLOYER: Asahi Kasei Corp.
LOCATION: Cary, NC (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-12
K401_MATCH: yes (not source-backed)
APPLY_URL: https://akamerica.wd501.myworkdayjobs.com/aka/job/Cary-NC/Manager--Pharmaceutical-Sales-Training_R5468-1
EXCERPT: Manager, Pharmaceutical Sales Training Cary, NC posted: Posted 30+ Days Ago
---
TITLE: Scientist, Pharmaceutical Development & Data Analytics _2 years temporary contract
EMPLOYER: Roche Holding AG
LOCATION: Basel, Basel-City, Switzerland (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-10
APPLY_URL: https://roche.wd3.myworkdayjobs.com/roche-ext/job/Basel/Scientist--Pharmaceutical-Development---Data-Analytics--2-years-temporary-contract_202604-110692-1/apply
EXCERPT: Scientist, Pharmaceutical Development & Data Analytics _2 years temporary contract Basel, Basel-City, Switzerland Leading development: Pharmaceutical development of parenteral formulations for clinical development and market (including line extensions). You bring hands-on experience applying data analytics to pha...
---
TITLE: Mid-Market Account Executive
EMPLOYER: MaintainX
LOCATION: USA, Canada (unspecified)
SALARY: Not disclosed
POSTED: 2025-01-23
APPLY_URL: https://job-boards.greenhouse.io/maintainx/jobs/4631985007
EXCERPT: Mid-Market Account Executive USA, Canada MaintainX is the world's leading AI-powered maintenance and asset management platform, serving 13,000+ customers including Duracell, Shell, Cintas, and Brenntag. We raised $150M in Series D funding led by Bessemer Venture Partners and Bain Capital Ventures, bringing our total funding to $254M. We were named to the Forbes 2025 Cloud 100 , the definitive ranking of the top 100 private cloud companies in the world. We're growing fast and hiring the talent team to match. We're currently looking for an Account Executive based in either Canada or the US, or in one of our primary hubs in Montreal, Toronto, or Raleigh. This role is unique and different from almost anything else currently available in the market as you will have full ownership and accountability within a defined market at MaintainX. While you will have numerous resources to ensure your success, you will be completely full-cycle: from prospecting, discovery, demo, to signature. The mid-market role covers companies from 250 to 5,000 employees in size, so it is vital you're able to manage longer, complex deal cycles while also closing more transactional deals as they come through. This is a difference-making, meaningful, high-responsibility role. We expect the right candidate to be someone who thinks outside the box, thrives under pressure, and is laser-focused on meeting targets every single month. What you'll do: - New Logo Sales - Your primary job responsibility will be to close new accounts and to consistently hit targets monthly, quarterly, and annually. -
---
TITLE: Director, US Value & Access
EMPLOYER: Ionis Pharmaceuticals
LOCATION: Remote (remote)
SALARY: Not disclosed
POSTED: 2026-06-10
K401_MATCH: yes (not source-backed)
APPLY_URL: https://recruiting.ultipro.com/isi1000isis/JobBoard/14a66400-68fa-4847-8593-af776328cfd2/OpportunityDetail?opportunityId=7f837f32-7173-4144-8d05-eb6982afb40e
EXCERPT: Director, US Value & Access Remote Click the title to view more details
---
TITLE: Buyer Planner NADC
EMPLOYER: Teleflex
LOCATION: Olive Branch, MS (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-12
APPLY_URL: https://careers.teleflex.com/job/Olive-Branch-Buyer-Planner-NADC-MS/1398410200/
EXCERPT: Buyer Planner NADC Olive Branch, MS Expected Travel: Requisition ID: 13914 About Teleflex Incorporated As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people's lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose-driven innovation, and world-class products can shape the future direction of healthcare. Teleflex is the home of Arrow™, Barrigel™, Deknatel™, LMA™, Pilling™, QuikClot™, Rüsch™, UroLift™ and Weck™ - trusted brands united by a common sense of purpose. At Teleflex, we are empowering the future of healthcare. For more information, please visit teleflex.com. Global Operations - Global Operations is a complex and diverse organization within the company which is responsible for product fulfilment to all our customers from end to end. We pride ourselves on being totally Customer Centric in our unrelenting focus on Improving Quality, Service and Value as perceived by our customers. Our employees are dedicated to the Global Operations Enterprise Excellence journey. Join a dynamic, growing team that offers healthcare providers an array of medical technology solutions that make a difference in patients' lives. Position Summary The role is responsible for synthesizing data, insights, and pla
---
TITLE: Global CDMO Compliance Officer
EMPLOYER: Fujifilm Holdings Corp.
LOCATION: Morrisville, NC, US (unspecified)
SALARY: $220K-$240K
POSTED: 2026-06-10
APPLY_URL: https://uscareershub-fujifilm.icims.com/jobs/37198/global-cdmo-compliance-officer/job
EXCERPT: Global CDMO Compliance Officer Morrisville, NC, US Position Overview FUJIFILM Holdings America Corporation is seeking an accomplished, talented, and highly motivated individual to serve as Global CDMO Compliance Officer for its FUJIFILM Biotechnologies business, a world-leading contract development and manufacturing organization (CDMO) for biologics, vaccines and advanced therapies. Reporting to the VP, Chief Compliance Officer of FUJIFILM Holdings America Corporation, this individual will serve as the leader of FUJIFILM Biotechnologies global compliance team. The person in this role will have extensive experience in the biotech or pharmaceutical space, will have strong leadership experience and business acumen. The individual will play a critical role in helping FUJIFILM Biotechnologies manage new and evolving compliance risks. This individual will support the leadership team and will have a dotted line reporting relationship to the FUJIFILM Biotechnologies CEO. This is a hybrid position located in North Carolina (Morrisville or Research Triangle Park) With connections across the FUJIFILM Biotechnologies business, as well as FUJIFILM Holdings America Corporation and the wider FUJIFILM group, the Global CDMO Compliance Officer, will be uniquely positioned to spot compliance risks and issues arising in business area and understand their impacts elsewhere to influence and enable senior management to make informed, business-driven decisions. The successful candidate will be expected to direct compliance strategy and help positio
---
TITLE: ServiceNow Developer
EMPLOYER: Cinemark Holdings Inc
LOCATION: CORP - Cinemark Service Center, Plano, TX (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-10
APPLY_URL: https://cinemark.wd1.myworkdayjobs.com/cinemark/job/CORP---Cinemark-Service-Center-Plano-TX/ServiceNow-Developer_R34941
EXCERPT: ServiceNow Developer CORP - Cinemark Service Center, Plano, TX posted: Posted 2 Days Ago
---
TITLE: Vice President, Commercial Manufacturing Operations
EMPLOYER: VERA Therapeutics INC
LOCATION: Remote (remote)
SALARY: $248K-$375K
POSTED: 2026-06-07
APPLY_URL: https://job-boards.greenhouse.io/veratherapeuticsinc/jobs/4273981009
EXCERPT: Vice President, Commercial Manufacturing Operations Remote Vera Therapeutics is a biotechnology company focused on developing treatments for serious immunological diseases. Vera Therapeutics' mission is to advance treatments that target the source of disease in order to change the standard of care for patients. Vera Therapeutics' lead product candidate is atacicept, a fusion protein self-administered at home as a subcutaneous once weekly injection that blocks both B-cell Activating Factor (BAFF) and A Proliferation-Inducing Ligand (APRIL), which stimulate B cells to produce autoantibodies contributing to certain autoimmune diseases, including IgA nephropathy (IgAN) and lupus nephritis. Beyond IgAN, Vera Therapeutics is evaluating additional diseases where the reduction of autoantibodies by atacicept may prove clinically meaningful. In addition, Vera Therapeutics holds an exclusive license agreement with Stanford University for a novel, next generation fusion protein targeting BAFF and APRIL, known as VT-109, with wide therapeutic potential across the spectrum of B-cell-mediated diseases. Vera Therapeutics is also evaluating the development of MAU868, a monoclonal antibody designed to neutralize infection with BK virus, which can have devastating consequences in kidney transplant recipients. Vera Therapeutics retains all global developmental and commercial rights to atacicept, VT-109, and MAU868. For more information, please visit www.veratx.com . Our values are the cornerstone of our culture. Our values inspire us every day and guide everything we do-from how we hire great people, to advancing our mission together, to achieving our ultimate goal to improve medical treatment for patients suffering from immunological diseases. Position Summary: The Vice President, Manufacturing Operations will report
---
TITLE: Senior Director, Beverages
EMPLOYER: Cinemark Holdings Inc
LOCATION: CORP - Cinemark Service Center, Plano, TX (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-12
APPLY_URL: https://cinemark.wd1.myworkdayjobs.com/cinemark/job/CORP---Cinemark-Service-Center-Plano-TX/Senior-Director--Beverages_R34800-1
EXCERPT: Senior Director, Beverages CORP - Cinemark Service Center, Plano, TX posted: Posted 30+ Days Ago
---
TITLE: Manager, Quality Assurance, Compliance
EMPLOYER: Vaxcyte Inc
LOCATION: San Carlos, California, United States (unspecified)
SALARY: $151K-$176K
POSTED: 2026-03-25
K401_MATCH: yes (not source-backed)
APPLY_URL: https://boards.greenhouse.io/vaxcyte/jobs/5155640008?gh_jid=5155640008
EXCERPT: Manager, Quality Assurance, Compliance San Carlos, California, United States Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: Vaxcyte is seeking a Manager, Quality Assurance, Compliance who is responsible for providing day-to-day operational oversight governance and strategic oversight of key Quality System processes, with a primary focus on leading Change Control governance and deviation/investigation oversight review board leadership. This role insures consistent, risk-based decision making, inspection readiness, and cross-functional accountability
---
TITLE: Workday Integrations Specialist
EMPLOYER: Cinemark Holdings Inc
LOCATION: CORP - Cinemark Service Center, Plano, TX (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-10
APPLY_URL: https://cinemark.wd1.myworkdayjobs.com/cinemark/job/CORP---Cinemark-Service-Center-Plano-TX/Workday-Integrations-Specialist_R36480
EXCERPT: Workday Integrations Specialist CORP - Cinemark Service Center, Plano, TX posted: Posted 2 Days Ago
---
TITLE: Associate Director, Computer Systems Assurance (Quality)
EMPLOYER: Nurix Therapeutics Inc
LOCATION: Brisbane, CA (unspecified)
SALARY: $190K-$216K
POSTED: 2026-05-05
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/nurix/jobs/8535914002
EXCERPT: Associate Director, Computer Systems Assurance (Quality) Brisbane, CA Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases. Powered by a fully AI-integrated discovery engine capable of tackling any protein class, and coupled with unparalleled ligase expertise, Nurix's dedicated team has built a formidable advantage in translating the science of targeted protein degradation into clinical advancements. Nurix aims to establish degrader-based treatments at the forefront of patient care, writing medicine's next chapter with a new script to outmatch disease. Position The Senior Manager / Associate Director, Computer Systems Assurance (CSA) is an important technical and operational leader within the Nurix Quality Systems organization, responsible for owning and advancing Nurix's computer systems assurance program. As a virtual drug developer, Nurix operates through a lean internal infrastructure and relies on a curated ecosystem of Software-as-a-Service (SaaS) and cloud-hosted platforms to support GxP-regulated activities across clinical development, quality operations, manufacturing oversight, and regulatory submissions. This role will serve as the primary subject matter expert and program owner for all CSA and computerized system validation (CSV) activities at Nurix. Reporting to the Vice President / Senior Director, Quality Systems, this individual will establish and maintain Nurix's risk-based CSA framework aligned with current regulatory expectations, including the FDA's 2022 guidance on computer software assurance, GAMP 5 (2nd edition), and applicable 21 CFR Part 11 and Annex
---
TITLE: VP, Global Treasury
EMPLOYER: Cinemark Holdings Inc
LOCATION: CORP - Cinemark Service Center, Plano, TX (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-12
APPLY_URL: https://cinemark.wd1.myworkdayjobs.com/cinemark/job/CORP---Cinemark-Service-Center-Plano-TX/VP--Global-Treasury_R34972
EXCERPT: VP, Global Treasury CORP - Cinemark Service Center, Plano, TX posted: Posted 30+ Days Ago
---
TITLE: Executive Director, Investor Relations
EMPLOYER: Entrada Therapeutics Inc
LOCATION: Boston, MA (unspecified)
SALARY: $292K-$335K
POSTED: 2026-03-12
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/entradatherapeutics/jobs/5077431007
EXCERPT: Executive Director, Investor Relations Boston, MA The Organization What's happening at Entrada Therapeutics? Entrada is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. Through proprietary and versatile approaches, Entrada is advancing a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases, among others. Our lead oligonucleotide programs are in development for the potential treatment of people living with Duchenne muscular dystrophy (DMD) who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered with Vertex Pharmaceuticals to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1 (DM1). 2026 represents a catalyst-rich period for Entrada. We expect multiple clinical data readouts as we advance several DMD programs across the U.K., EU, and U.S. By year-end 2026, we anticipate four clinical-stage programs in our DMD franchise (ENTR-601-44, ENTR-601-45, ENTR-601-50, and ENTR-601-51). These programs are complemented by the ongoing clinical progress of our DM1 collaboration with Vertex (VX-670). We are a tight-knit team of experts and leaders in both therapeutic development and rare diseases and are excited to grow and attract colleagues who are ready to join a high-energy, dedicated team that likes to get things done and dramatically improve the lives of patients and their families. The Perfect Addition to Our Team You are intellectually curious and can bring new ideas and perspectives to lead the development, implementation, and management of our
---
TITLE: Lead Data Scientist
EMPLOYER: Cinemark Holdings Inc
LOCATION: CORP - Cinemark Service Center, Plano, TX (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-05
APPLY_URL: https://cinemark.wd1.myworkdayjobs.com/cinemark/job/CORP---Cinemark-Service-Center-Plano-TX/Lead-Data-Scientist_R34881
EXCERPT: Lead Data Scientist CORP - Cinemark Service Center, Plano, TX posted: Posted 7 Days Ago
---
TITLE: Associate Director, Global Drug Substance Commercialization, Critical Raw Materials
EMPLOYER: Vaxcyte Inc
LOCATION: San Carlos, California, United States (unspecified)
SALARY: $174K-$203K
POSTED: 2025-11-07
K401_MATCH: yes (not source-backed)
APPLY_URL: https://boards.greenhouse.io/vaxcyte/jobs/4974572008?gh_jid=4974572008
EXCERPT: Associate Director, Global Drug Substance Commercialization, Critical Raw Materials San Carlos, California, United States Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: The Associate Director for Drug Substance (DS) Commercialization has the accountability for launch readiness and commercial supply of associated raw materials for production of eCRM and associated components for glycoconjugate vaccines. This role focuses on technical launch planning and execution by bringing best-practices and coordinating cross-functional efforts
---
TITLE: Senior Project Manager
EMPLOYER: Cinemark Holdings Inc
LOCATION: CORP - Cinemark Service Center, Plano, TX (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-12
APPLY_URL: https://cinemark.wd1.myworkdayjobs.com/cinemark/job/CORP---Cinemark-Service-Center-Plano-TX/Senior-Project-Manager_R36294
EXCERPT: Senior Project Manager CORP - Cinemark Service Center, Plano, TX posted: Posted 30+ Days Ago
---
TITLE: Executive Director, Total Rewards
EMPLOYER: Xenon Pharmaceuticals
LOCATION: Vancouver | [Hybrid] | Remote (hybrid)
SALARY: Not disclosed
POSTED: 2026-06-10
APPLY_URL: https://jobs.ashbyhq.com/xenon/66a87f03-02a8-427a-978a-93b0068eb238
EXCERPT: Executive Director, Total Rewards Vancouver | [Hybrid] | Remote
---
TITLE: Senior Financial Analyst - Anaplan
EMPLOYER: Cinemark Holdings Inc
LOCATION: CORP - Cinemark Service Center, Plano, TX (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-12
APPLY_URL: https://cinemark.wd1.myworkdayjobs.com/cinemark/job/CORP---Cinemark-Service-Center-Plano-TX/Anaplan-Model-Builder---Food---Beverage-Finance_R36185
EXCERPT: Senior Financial Analyst - Anaplan CORP - Cinemark Service Center, Plano, TX posted: Posted 30+ Days Ago
---
TITLE: Global L&D Quality Manager, Supplier Quality and Shipholds
EMPLOYER: Teleflex
LOCATION: Olive Branch, MS (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-12
APPLY_URL: https://careers.teleflex.com/job/Olive-Branch-Global-L&D-Quality-Manager%2C-Supplier-Quality-and-Shipholds-MS/1382983000/
EXCERPT: Global L&D Quality Manager, Supplier Quality and Shipholds Olive Branch, MS Expected Travel: Requisition ID: 13678 About Teleflex Incorporated As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people's lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose-driven innovation, and world-class products can shape the future direction of healthcare. Teleflex is the home of Arrow™, Barrigel™, Deknatel™, LMA™, Pilling™, QuikClot™, Rüsch™, UroLift™ and Weck™ - trusted brands united by a common sense of purpose. At Teleflex, we are empowering the future of healthcare. For more information, please visit teleflex.com. Global Operations - Global Operations is a complex and diverse organization within the company which is responsible for product fulfilment to all our customers from end to end. We pride ourselves on being totally Customer Centric in our unrelenting focus on Improving Quality, Service and Value as perceived by our customers. Our employees are dedicated to the Global Operations Enterprise Excellence journey. Join a dynamic, growing team that offers healthcare providers an array of medical technology solutions that make a difference in patients' lives. Position Summary This role ensures compliance with ISO 13485, ISO 9001, FDA regul
---
TITLE: Director, Data Solutions & Engineering
EMPLOYER: Cinemark Holdings Inc
LOCATION: CORP - Cinemark Service Center, Plano, TX (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-12
APPLY_URL: https://cinemark.wd1.myworkdayjobs.com/cinemark/job/CORP---Cinemark-Service-Center-Plano-TX/Director--Data-Solutions---Engineering_R34638
EXCERPT: Director, Data Solutions & Engineering CORP - Cinemark Service Center, Plano, TX posted: Posted 30+ Days Ago
---
TITLE: Associate Director, Regulatory Strategy
EMPLOYER: Syndax Pharmaceuticals Inc
LOCATION: New York, NY (unspecified)
SALARY: $200K-$225K
POSTED: 2026-03-09
K401_MATCH: yes (not source-backed)
APPLY_URL: https://syndax.com/join-us/careers/?gh_jid=5819781004
EXCERPT: Associate Director, Regulatory Strategy New York, NY Syndax Pharmaceuticals is looking for an Associate Director, Regulatory Strategy At Syndax, we are determined to realize a future in which people with cancer live longer and better than ever before. Syndax Pharmaceuticals is a commercial stage biopharmaceutical company developing an innovative pipeline of cancer therapies. The Role: The Associate Director, Regulatory Strategy will be responsible for developing and implementing regulatory strategies to secure global investigational and marketing applications for assigned product(s) in the assigned therapeutic area. Leads the Product Regulatory Sub team. Ensures strategic messaging and content of global regulatory dossiers. May serve as the primary regulatory interface with the Asset Strategy Team and sub teams. Proactively anticipates and mitigates regulatory risks. Ensures compliance with global regulatory requirements. Manages assets through all phases of development from pre-FIH through active life cycle management activities. Demonstrates an understanding of drug development and exhibits leadership behaviors consistent with level. Has direct experience with regulatory acceleration strategies, developing regulatory strategy, analyzing regulatory precedence and operational excellence in execution of regulatory strategy. This role may lead a team of regulatory professionals. Key Responsibilities: - Ensure the development and flawless execution of regulatory strategies for the assigned products/projects. - Strategic partner for internal cross functional stakeholders both within and external to the regulatory organization.. - Represents Syndax to regulatory health authorities, e.g. FDA, for all products and businesses. - Lead the preparation of submissions, which may include INDs, Briefing Documents, Orphan Drug Applications, and Marketing Applications, etc. Work
---
TITLE: Senior Manager, Procurement Enablement
EMPLOYER: Cinemark Holdings Inc
LOCATION: CORP - Cinemark Service Center, Plano, TX (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-12
APPLY_URL: https://cinemark.wd1.myworkdayjobs.com/cinemark/job/CORP---Cinemark-Service-Center-Plano-TX/Senior-Manager--Purchasing_R34740
EXCERPT: Senior Manager, Procurement Enablement CORP - Cinemark Service Center, Plano, TX posted: Posted 30+ Days Ago
---
TITLE: Contracts & Integration Lead (REMOTE)
EMPLOYER: Teleflex
LOCATION: Contracts & Integration Lead (REMOTE) (remote)
SALARY: $100K-$151K
POSTED: 2026-06-12
APPLY_URL: https://careers.teleflex.com/job/Remote-Contracts-&-Integration-Lead-%28REMOTE%29-MA-01468/1391350400/
EXCERPT: Contracts & Integration Lead (REMOTE) Contracts & Integration Lead (REMOTE) Expected Travel: Requisition ID: 13813 About Teleflex Incorporated As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people's lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose-driven innovation, and world-class products can shape the future direction of healthcare. Teleflex is the home of Arrow™, Barrigel™, Deknatel™, LMA™, Pilling™, QuikClot™, Rüsch™, UroLift™ and Weck™ - trusted brands united by a common sense of purpose. At Teleflex, we are empowering the future of healthcare. For more information, please visit teleflex.com. OEM - Teleflex Medical OEM is a leading global provider of product development and production services for medical device manufacturers. We set ourselves apart with deep expertise, decades of experience, a dedication to design for manufacturability, and extensive, in-house capabilities, which include engineering, regulatory services, material selection and formulation, prototyping, manufacturing, assembly and packaging. We deliver industry-changing innovations and next-generation solutions for extrusions; diagnostic and interventional catheters; balloons and balloon catheters; sheath/dilator sets; specialty sutures, braids and fi
---
TITLE: Senior Category Manager – Food & Beverage
EMPLOYER: Cinemark Holdings Inc
LOCATION: CORP - Cinemark Service Center, Plano, TX (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-08
APPLY_URL: https://cinemark.wd1.myworkdayjobs.com/cinemark/job/CORP---Cinemark-Service-Center-Plano-TX/Senior-Manager--Culinary-Operations_R34698
EXCERPT: Senior Category Manager – Food & Beverage CORP - Cinemark Service Center, Plano, TX posted: Posted 4 Days Ago
---
TITLE: Director, Clinical Data Management
EMPLOYER: Syndax Pharmaceuticals Inc
LOCATION: New York, NY (unspecified)
SALARY: $220K-$250K
POSTED: 2025-11-03
K401_MATCH: yes (not source-backed)
APPLY_URL: https://syndax.com/join-us/careers/?gh_jid=5695039004
EXCERPT: Director, Clinical Data Management New York, NY Syndax Pharmaceuticals is looking for a Director, Clinical Data Management At Syndax, we are determined to realize a future in which people with cancer live longer and better than ever before. Syndax Pharmaceuticals is a commercial stage biopharmaceutical company developing an innovative pipeline of cancer therapies. The Role: This position is a strategic leader responsible for overseeing the design, implementation, and oversight of clinical data systems and processes across multiple clinical development programs. This role directs a team in delivering high-quality clinical data in alignment with regulatory requirements, corporate goals, and operational efficiency. The Director contributes to the long-term success of the function through data-driven strategies, innovation in systems and processes, and strong cross-functional partnerships. May also be responsible for projects that have been contracted with a service provider, as well as internal projects. Key Responsibilities: - Collaborate with senior leadership to define and implement functional and organizational strategy aligned with corporate objectives; participate in long-term planning and policy development. - Development and execution of data quality strategies, risk-based data review plans, and cross-study harmonization. - Direct the design, testing, validation, and maintenance of clinical databases and electronic data capture (EDC) systems. - Ensure consistent application of CDM standards, tools (e.g., CDISC, Medidata Rave), and procedures. - Oversee issue resolution and data integrity across outsourced vendors and internal teams. - Provide proactive input into clinical protocol design to ensure data collection strategies align with scientific and regulatory requirements. - Review and contribute to
---
TITLE: Senior Category Manager - Food & Beverage
EMPLOYER: Cinemark Holdings Inc
LOCATION: CORP - Cinemark Service Center, Plano, TX (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-12
APPLY_URL: https://cinemark.wd1.myworkdayjobs.com/cinemark/job/CORP---Cinemark-Service-Center-Plano-TX/Sr-Category-Manager---Food---Beverage--Pre-Packaged---Popcorn-_R34995
EXCERPT: Senior Category Manager - Food & Beverage CORP - Cinemark Service Center, Plano, TX posted: Posted 30+ Days Ago
---
TITLE: Director, Clinical Affairs, Interventional (REMOTE)
EMPLOYER: Teleflex
LOCATION: Director, Clinical Affairs, Interventional (REMOTE) (remote)
SALARY: $187K-$280K
POSTED: 2026-06-12
APPLY_URL: https://careers.teleflex.com/job/minneapolis-Director%2C-Clinical-Affairs%2C-Interventional-%28REMOTE%29-MN-55401/1391331900/
EXCERPT: Director, Clinical Affairs, Interventional (REMOTE) Director, Clinical Affairs, Interventional (REMOTE) Expected Travel: Requisition ID: 13837 About Teleflex Incorporated As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people's lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose-driven innovation, and world-class products can shape the future direction of healthcare. Teleflex is the home of Arrow™, Barrigel™, Deknatel™, LMA™, Pilling™, QuikClot™, Rüsch™, UroLift™ and Weck™ - trusted brands united by a common sense of purpose. At Teleflex, we are empowering the future of healthcare. For more information, please visit teleflex.com. Interventional - The Interventional business unit at Teleflex develops innovative medical devices used to diagnose and treat coronary and peripheral vascular diseases. We focus strategically on coronary and peripheral interventions, vascular and bone access, and large-bore closure solutions. Our portfolio includes a broad range of clinically relevant products, such as the GuideLiner™ and Turnpike™ Catheters; the Orsiro™ Mission™ Drug-Eluting Stent; the PK Papyrus™ Covered Coronary Stent; the Ringer™ Perfusion Balloon Catheter; the Pulsar™ -18 T3 Self-Expanding Stent; Passeo™ Balloon Catheters; and the OnControl™ Powered Bone Acce
---
TITLE: Senior Data Solutions & Engineering Architect
EMPLOYER: Cinemark Holdings Inc
LOCATION: CORP - Cinemark Service Center, Plano, TX (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-12
APPLY_URL: https://cinemark.wd1.myworkdayjobs.com/cinemark/job/CORP---Cinemark-Service-Center-Plano-TX/Senior-Data-Solutions---Engineering-Architect_R34661
EXCERPT: Senior Data Solutions & Engineering Architect CORP - Cinemark Service Center, Plano, TX posted: Posted 30+ Days Ago
---
TITLE: Financial Analyst
EMPLOYER: Teleflex
LOCATION: Coventry, CT (unspecified)
SALARY: $87K-$131K
POSTED: 2026-06-12
APPLY_URL: https://careers.teleflex.com/job/Coventry-Financial-Analyst-CT/1382094200/
EXCERPT: Financial Analyst Coventry, CT Expected Travel: Requisition ID: 13665 About Teleflex Incorporated As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people's lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose-driven innovation, and world-class products can shape the future direction of healthcare. Teleflex is the home of Arrow™, Barrigel™, Deknatel™, LMA™, Pilling™, QuikClot™, Rüsch™, UroLift™ and Weck™ - trusted brands united by a common sense of purpose. At Teleflex, we are empowering the future of healthcare. For more information, please visit teleflex.com. OEM - Teleflex Medical OEM is a leading global provider of product development and production services for medical device manufacturers. We set ourselves apart with deep expertise, decades of experience, a dedication to design for manufacturability, and extensive, in-house capabilities, which include engineering, regulatory services, material selection and formulation, prototyping, manufacturing, assembly and packaging. We deliver industry-changing innovations and next-generation solutions for extrusions; diagnostic and interventional catheters; balloons and balloon catheters; sheath/dilator sets; specialty sutures, braids and fi
---
TITLE: Director, Category Management Energy & Utilities
EMPLOYER: Cinemark Holdings Inc
LOCATION: CORP - Cinemark Service Center, Plano, TX (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-12
APPLY_URL: https://cinemark.wd1.myworkdayjobs.com/cinemark/job/CORP---Cinemark-Service-Center-Plano-TX/Director--Energy---Utilities_R34944
EXCERPT: Director, Category Management Energy & Utilities CORP - Cinemark Service Center, Plano, TX posted: Posted 30+ Days Ago
---
TITLE: Senior Director, Product Launch Lead VAX-31
EMPLOYER: Vaxcyte Inc
LOCATION: San Carlos, California, United States (unspecified)
SALARY: $271K-$316K
POSTED: 2026-01-20
K401_MATCH: yes (not source-backed)
APPLY_URL: https://boards.greenhouse.io/vaxcyte/jobs/5071525008?gh_jid=5071525008
EXCERPT: Senior Director, Product Launch Lead VAX-31 San Carlos, California, United States Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: Vaxcyte is seeking a Senior Director, Launch Lead, VAX-31, to lead strategic planning and execution of the company's first launch of VAX-31. This role will coordinate cross-functional activities from late-stage development through market entry, ensuring readiness across supply chain, regulatory, medical affairs, commercial operations, communications, and other functions. The position
---
TITLE: FSP SCRA I（Changsha）
EMPLOYER: Fortrea Holdings Inc
LOCATION: Shanghai, China (unspecified)
SALARY: Not disclosed
POSTED: 2024-12-18
K401_MATCH: yes (not source-backed)
APPLY_URL: https://fortrea.wd1.myworkdayjobs.com/Fortrea/job/Shanghai/FSP-SCRA-I-Changsha-_2447386/apply
EXCERPT: FSP SCRA I（Changsha） Shanghai, China As a leading global contract research organization (CRO) with a passion for scientific rigor and decades of clinical development experience, Fortrea provides pharmaceutical, biotechnology, and med...
---
TITLE: Stability Manager
EMPLOYER: Vaxcyte Inc
LOCATION: San Carlos, California, United States (unspecified)
SALARY: $147K-$171K
POSTED: 2025-09-02
K401_MATCH: yes (not source-backed)
APPLY_URL: https://boards.greenhouse.io/vaxcyte/jobs/4892976008?gh_jid=4892976008
EXCERPT: Stability Manager San Carlos, California, United States Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: Vaxcyte is looking for an energetic and talented individual to join Vaxcyte's Vaccine Product Development organization as a Stability Manager within the Quality Control Unit. The primary function of this level position is to manage the stability program for various projects in preclinical and clinical development. The position will be an integral part of
---
TITLE: Finance Manager - G&A, Workforce Planning & Incentives
EMPLOYER: Cinemark Holdings Inc
LOCATION: CORP - Cinemark Service Center, Plano, TX (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-12
APPLY_URL: https://cinemark.wd1.myworkdayjobs.com/cinemark/job/CORP---Cinemark-Service-Center-Plano-TX/Finance-Manager---G-A--Workforce-Planning---Incentives_R36284
EXCERPT: Finance Manager - G&A, Workforce Planning & Incentives CORP - Cinemark Service Center, Plano, TX posted: Posted 30+ Days Ago
---
TITLE: Category Manager F&B Digital Strategy
EMPLOYER: Cinemark Holdings Inc
LOCATION: CORP - Cinemark Service Center, Plano, TX (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-12
APPLY_URL: https://cinemark.wd1.myworkdayjobs.com/cinemark/job/CORP---Cinemark-Service-Center-Plano-TX/Category-Manager-F-B-Digital-Strategy_R36226
EXCERPT: Category Manager F&B Digital Strategy CORP - Cinemark Service Center, Plano, TX posted: Posted 30+ Days Ago
---
TITLE: Business Development Director
EMPLOYER: OpenX Technologies
LOCATION: US - Remote (remote)
SALARY: Not disclosed
POSTED: 2026-04-14
APPLY_URL: https://jobs.lever.co/openx/05b043ff-e436-4431-bdd5-50542fd1f597
EXCERPT: Business Development Director US - Remote Company at a Glance OpenX is focused on unleashing the full economic potential of digital media companies. We do this by making digital advertising markets and technologies that are designed to deliver optimal value to publishers and advertisers on every ad served across all screens. At OpenX, we have built a team that is uniquely experienced in designing and operating high-scale ad marketplaces, and we are constantly on the lookout for thoughtful, creative executors who are as fascinated as we are about finding new ways to apply a blend of market design, technical innovation, operational excellence, and empathetic partner service to the frontiers of digital advertising. OpenX is seeking a Business Development Senior Director with significant experience in the CTV and programmatic ecosystem. This executive will represent OpenX to leading CTV publishers, streaming platforms, broadcasters, and other premium video supply partners. The focus of this role will be on identifying and securing strategic, long-term CTV partnerships that leverage the OpenX exchange, PMP platform, identity and data assets, OpenXSelect, and our CTV publisher product suite to drive increased value for publishers and OpenX. The Business Development Senior Director is a senior member of the Publisher Development team and is expected to leverage deep knowledge of the CTV landscape and programmatic ecosystem to bring on new premium CTV supply, enhance and improve our CTV product offerings, refine our value proposition, and broaden our understanding of the markets in which we compete. This person will own OpenX's
---
TITLE: International Clinical Analyst
EMPLOYER: Genedx Holdings CORP
LOCATION: Remote (remote)
SALARY: Not disclosed
POSTED: 2026-06-12
K401_MATCH: yes (not source-backed)
APPLY_URL: https://genedx.com/careers/openings?gh_jid=4704807005
EXCERPT: International Clinical Analyst Remote GeneDx (Nasdaq: WGS) delivers personalized and actionable health insights to inform diagnosis, direct treatment, and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation services, fueled by the world's largest, rare disease data sets. For more information, please visit www.genedx.com . Summary The Clinical Analyst II (AMBGG certified) serves as a key contributor to the interpretation of genetic findings, supports accurate diagnosis and case resolution through exome and genome sequencing workflows. This mid-level role builds on foundational clinical analysis competencies by performing independent case reviews with minimal supervision. Job Responsibilities Independently perform clinical data analysis and case management to support accurate interpretation of genetic findings, including reanalysis activities. Establish phenotype-genotype correlations across a wide range of genetic disorders using internal resources and professional tools. Investigates and interprets complex clinical features of genetic conditions; documents evidence and rationale for variant classification in a clear, standardized format. Meets or exceeds productivity and error standards as assigned by team lead. Perform clinical analysis at moderate case rate. Perform other duties as assigned to advance team objectives. People Manager No Education, Experience, and Skills PhD in Biology, Genetics or related field, MD or DO with more than 2 years directly relevant experience in clinical diagnostics (including fellowship) Excellent verbal and written communication skills Demonstrated computer
---
TITLE: Apprentice - Visual Design
EMPLOYER: Fortrea Holdings Inc
LOCATION: BANGALORE, Karnātaka, India (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-05
K401_MATCH: yes (not source-backed)
APPLY_URL: https://fortrea.wd1.myworkdayjobs.com/Fortrea/job/Bangalore/Apprentice---Visual-Design_263011/apply
EXCERPT: Apprentice - Visual Design BANGALORE, Karnātaka, India As a leading global contract research organization (CRO) with a passion for scientific rigor and decades of clinical development experience, Fortrea provides pharmaceutical, biotechnology, and medi...
---
TITLE: Apprentice - Employer Branding
EMPLOYER: Fortrea Holdings Inc
LOCATION: BANGALORE, Karnātaka, India (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-05
K401_MATCH: yes (not source-backed)
APPLY_URL: https://fortrea.wd1.myworkdayjobs.com/Fortrea/job/Bangalore/Apprentice---Employer-Branding_263009/apply
EXCERPT: Apprentice - Employer Branding BANGALORE, Karnātaka, India As a leading global contract research organization (CRO) with a passion for scientific rigor and decades of clinical development experience, Fortrea provides pharmaceutical, biotechnology, and medi...
---
TITLE: Instrument Buyer II
EMPLOYER: Teleflex
LOCATION: Morrisville, NC (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-12
APPLY_URL: https://careers.teleflex.com/job/Morrisville-Instrument-Buyer-II-NC-27560/1391031900/
EXCERPT: Instrument Buyer II Morrisville, NC Expected Travel: Requisition ID: 13825 About Teleflex Incorporated As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people's lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose-driven innovation, and world-class products can shape the future direction of healthcare. Teleflex is the home of Arrow™, Barrigel™, Deknatel™, LMA™, Pilling™, QuikClot™, Rüsch™, UroLift™ and Weck™ - trusted brands united by a common sense of purpose. At Teleflex, we are empowering the future of healthcare. For more information, please visit teleflex.com. Global Operations - Global Operations is a complex and diverse organization within the company which is responsible for product fulfilment to all our customers from end to end. We pride ourselves on being totally Customer Centric in our unrelenting focus on Improving Quality, Service and Value as perceived by our customers. Our employees are dedicated to the Global Operations Enterprise Excellence journey. Join a dynamic, growing team that offers healthcare providers an array of medical technology solutions that make a difference in patients' lives. Position Summary The Instrument Buyer II will optimize the use of company assets
---
TITLE: Counsel, Corporate and Fintech Products
EMPLOYER: FalconX
LOCATION: New York City, NY (unspecified)
SALARY: $196K-$248K
POSTED: 2026-03-06
APPLY_URL: https://job-boards.greenhouse.io/falconx/jobs/4668542005
EXCERPT: Counsel, Corporate and Fintech Products New York City, NY Who are we? FalconX is a pioneering team of operators, investors, and builders committed to revolutionizing institutional access to the crypto markets. Operating at the intersection of traditional finance and cutting-edge technology, FalconX addresses the industry's foremost challenges: Navigating the digital asset market can be complex and fragmented, with limited products and services that support trading strategies, structures, and liquidity found in conventional financial markets. As a comprehensive solution for all digital asset strategies from start to scale, FalconX operates as the connective tissue empowering clients with seamless navigation through the ever- evolving cryptocurrency landscape. About the Role As Counsel, Corporate and FinTech Product , you will be a cornerstone of the FalconX legal team, driving the execution of our global commercial strategy while safeguarding the firm's corporate integrity. You will provide strategic legal guidance across a broad spectrum of corporate, regulatory, and transactional matters. This role requires a high-energy "builder" mindset, working cross-functionally to support rapid business initiatives and ensuring compliance with evolving global regulations. Responsibilities - Commercial Contracting: Lead the drafting, negotiation, and review of complex commercial agreements, including SaaS licensing, strategic partnerships, vendor services, and client-facing institutional trading agreements. - Corporate Governance: Provide legal counsel on corporate governance frameworks, manage entity management tasks, and assist in preparing materials for Board of Directors meetings. - Intellectual Property: Oversee and protect FalconX's IP portfolio, including managing trademark filings, advising on patent strategy, and ensuring IP protections are robust in all
---
TITLE: Assistant Buyer- Grocery
EMPLOYER: Grocery Outlet Holding Corp
LOCATION: Emeryville Corp Hybrid (hybrid)
SALARY: Not disclosed
POSTED: 2026-05-27
APPLY_URL: https://recruiting.ultipro.com/GRO1006/JobBoard/4c6ab91f-73c0-bb4f-ad81-094171fac4c7/OpportunityDetail?opportunityId=8081f895-5e3c-4c94-8ce3-5c54d1882c7d
EXCERPT: Assistant Buyer- Grocery Emeryville Corp Hybrid The focus of this role is to assist the buyers with their daily responsibilities. This role ensures accuracy in the ordering process while facilitating communications between vendors, corresponding buyers, stores, and other departments within the company. This role reports to a Buyer on the team. This role reports to a Buyer on the Grocery team.
---
TITLE: Director, Corporate Bkg - Mainland Corp - Hang Seng Bank (HK)
EMPLOYER: HSBC Holdings plc
LOCATION: Central, Hong Kong Island, Hong Kong (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-12
K401_MATCH: yes (not source-backed)
APPLY_URL: https://portal.careers.hsbc.com/careers/job/563774611448165
EXCERPT: Director, Corporate Bkg - Mainland Corp - Hang Seng Bank (HK) Central, Hong Kong Island, Hong Kong
---
TITLE: Instrument Buyer
EMPLOYER: Teleflex
LOCATION: Morrisville, NC (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-12
APPLY_URL: https://careers.teleflex.com/job/Morrisville-Instrument-Buyer-NC-27560/1391031500/
EXCERPT: Instrument Buyer Morrisville, NC Expected Travel: Requisition ID: 13823 About Teleflex Incorporated As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people's lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose-driven innovation, and world-class products can shape the future direction of healthcare. Teleflex is the home of Arrow™, Barrigel™, Deknatel™, LMA™, Pilling™, QuikClot™, Rüsch™, UroLift™ and Weck™ - trusted brands united by a common sense of purpose. At Teleflex, we are empowering the future of healthcare. For more information, please visit teleflex.com. Global Operations - Global Operations is a complex and diverse organization within the company which is responsible for product fulfilment to all our customers from end to end. We pride ourselves on being totally Customer Centric in our unrelenting focus on Improving Quality, Service and Value as perceived by our customers. Our employees are dedicated to the Global Operations Enterprise Excellence journey. Join a dynamic, growing team that offers healthcare providers an array of medical technology solutions that make a difference in patients' lives. Position Summary The Instrument Buyer will optimize the use of company assets in
---
TITLE: Vice President, U.S. Market Access & Pricing
EMPLOYER: Vaxcyte Inc
LOCATION: San Carlos, California, United States (unspecified)
SALARY: $333K-$388K
POSTED: 2026-06-04
K401_MATCH: yes (not source-backed)
APPLY_URL: https://boards.greenhouse.io/vaxcyte/jobs/5236929008?gh_jid=5236929008
EXCERPT: Vice President, U.S. Market Access & Pricing San Carlos, California, United States Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: The Vice President, Market Access will lead the strategy and execution of all market access activities to support the successful launch of the company's adult pneumococcal vaccine. Reporting to the Chief Commercial Officer, this role will be accountable for ensuring broad, timely, and sustainable access across public and private
---
TITLE: Clinical Trial Assistant
EMPLOYER: Fortrea Holdings Inc
LOCATION: Warsaw, Poland (unspecified)
SALARY: Not disclosed
POSTED: 2026-04-10
K401_MATCH: yes (not source-backed)
APPLY_URL: https://fortrea.wd1.myworkdayjobs.com/Fortrea/job/Warsaw/Clinical-Trial-Assistant_261829/apply
EXCERPT: Clinical Trial Assistant Warsaw, Poland Fortrea is looking for an experienced Clinical Trial Assistant to support global clinical studies within an FSP model for a leading pharmaceutical sponsor. What you'll do. Support clinical trials e...
---
TITLE: Sr CRA I
EMPLOYER: Fortrea Holdings Inc
LOCATION: Buenos Aires, Buenos Aires, Argentina (unspecified)
SALARY: Not disclosed
POSTED: 2024-12-26
K401_MATCH: yes (not source-backed)
APPLY_URL: https://fortrea.wd1.myworkdayjobs.com/Fortrea/job/Buenos-Aires/Sr-CRA-I_2434170/apply
EXCERPT: Sr CRA I Buenos Aires, Buenos Aires, Argentina As a leading global contract research organization (CRO) with a passion for scientific rigor and decades of clinical development experience, Fortrea provides pharmaceutical, biotechnology, and medi...
---
TITLE: Counsel, Regulatory and Product
EMPLOYER: FalconX
LOCATION: New York City, NY (unspecified)
SALARY: $196K-$248K
POSTED: 2026-04-29
APPLY_URL: https://job-boards.greenhouse.io/falconx/jobs/4683543005
EXCERPT: Counsel, Regulatory and Product New York City, NY Who are we? FalconX is a pioneering team of operators, investors, and builders committed to revolutionizing institutional access to the crypto markets. Operating at the intersection of traditional finance and cutting-edge technology, FalconX addresses the industry's foremost challenges: Navigating the digital asset market can be complex and fragmented, with limited products and services that support trading strategies, structures, and liquidity found in conventional financial markets. As a comprehensive solution for all digital asset strategies from start to scale, FalconX operates as the connective tissue empowering clients with seamless navigation through the ever- evolving cryptocurrency landscape. The Role As Counsel, Regulatory & Product, you will play a lead role in FalconX's global regulatory footprint. Reporting to the Lead Attorney, you will own the execution of our 2026 licensing roadmap and ensure our product suite remains the "Gold Standard" for institutional compliance. You are a specialist who thrives at the intersection of evolving law and cutting-edge financial technology. What You Will Do - Execute the Licensing Roadmap: Directly manage and execute new license applications (VASP, MTL, and international equivalents) across all 2026 target jurisdictions. - Product Compliance Ownership: Partner with Product and Engineering from ideation to launch, providing the regulatory guardrails for new asset classes and trading features. - Regulatory Liaison: Act as a primary point of contact for regulatory inquiries, examinations, and reporting requirements, ensuring 100% standing with global oversight bodies. - Landscape Analysis: Monitor global legislative shifts (MiCA, SEC/CFTC developments, etc.) and
---
TITLE: Sr. Director, Head of Regulatory & Medical Writing
EMPLOYER: Nurix Therapeutics Inc
LOCATION: Brisbane, California, United States (unspecified)
SALARY: $254K-$289K
POSTED: 2026-05-09
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/nurix/jobs/8542236002
EXCERPT: Sr. Director, Head of Regulatory & Medical Writing Brisbane, California, United States Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases. Powered by a fully AI-integrated discovery engine capable of tackling any protein class, and coupled with unparalleled ligase expertise, Nurix's dedicated team has built a formidable advantage in translating the science of targeted protein degradation into clinical advancements. Nurix aims to establish degrader-based treatments at the forefront of patient care, writing medicine's next chapter with a new script to outmatch disease. Job Summary: As a key member of the cross-functional Development Team responsible for providing regulatory writing expertise and leadership to formulate the writing strategy for key regulatory documents for submission. The Sr. Director, Head of Regulatory & Medical Writing will be responsible for providing guidance to the medical and or regulatory writing group (contractors and internal writers) assigned to deliverables and ensuring appropriate work allocation and document preparation.; will also provide review and substantive editing of documents to ensure delivery of high-quality documents. This individual will work effectively with many other functional groups, including with Clinical Scientist(s), Medical Monitors, Regulatory and other functions as applicable, and collaborate with clinical medical writing as applicable to ensure scientific excellence in the execution of clinical trials. The Head of Regulatory Writing will build a medical writing group internally when appropriate. Reporting
---
TITLE: Sales Executive
EMPLOYER: Repay Holdings Corp
LOCATION: Atlanta Headquarters (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-12
APPLY_URL: https://repay.wd1.myworkdayjobs.com/REPAYCareers/job/Atlanta-Headquarters/Sales-Executive_JR508
EXCERPT: Sales Executive Atlanta Headquarters posted: Posted 30+ Days Ago
---
TITLE: Director of Quality Assurance, Alliance Management
EMPLOYER: Cytokinetics INC
LOCATION: Dublin, Dublin, Ireland (unspecified)
SALARY: Not disclosed
POSTED: 2026-04-14
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/cytokinetics/jobs/8506558002
EXCERPT: Director of Quality Assurance, Alliance Management Dublin, Dublin, Ireland Cytokinetics is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle performance is compromised. As a leader in muscle biology and the mechanics of muscle performance, the company is developing small molecule drug candidates specifically engineered to impact myocardial muscle function and contractility. We are seeking an experienced Director of Quality Assurance, Alliance Management to join our growing global organization. As Cytokinetics expands through strategic in-licensing partnerships with regional market leaders, this role will be critical in ensuring that all quality and compliance aspects of these partnerships are effectively established and maintained. This position will lead and coordinate Quality Assurance activities across partner relationships, ensuring alignment with global regulatory requirements and internal standards. The successful candidate will act as a key liaison between Cytokinetics and its partners, supporting both the onboarding of new alliances and the ongoing management of established collaborations. The role reports to the Head of Quality Assurance Operations and works closely with Alliance Management, Technical Operations, Regulatory CMC, and other cross-functional teams. Key Responsibilities Serve as a core member of the QA Operations team and Point of Contact (POC), coordinating quality requirements arising from partnership activities, in partnership with alliance management teams Lead and manage all Quality Assurance activities related to the onboarding of new partners Develop scalable frameworks, models, and processes for partner onboarding and QA integration
---
TITLE: Product Owner
EMPLOYER: Repay Holdings Corp
LOCATION: Remote - US (remote)
SALARY: Not disclosed
POSTED: 2026-05-12
APPLY_URL: https://repay.wd1.myworkdayjobs.com/REPAYCareers/job/Remote---US/Product-Owner_JR590
EXCERPT: Product Owner Remote - US posted: Posted 30+ Days Ago
---
TITLE: VP, Investor Relations
EMPLOYER: Ceribell Inc
LOCATION: Sunnyvale, CA (unspecified)
SALARY: $280K-$325K
POSTED: 2026-04-15
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/ceribell/jobs/5970231004
EXCERPT: VP, Investor Relations Sunnyvale, CA About Ceribell Ceribell is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Ceribell System is a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting, and is being used in hundreds of community hospitals, large academic facilities and major IDN's across the country. Our entire team is driven by a shared commitment to transforming the landscape of critical care through our rapid seizure detection technology, come join the movement! We are seeking a dynamic and strategic Vice President, Investor Relations to lead our engagement across our investment community. This key role will serve as the primary architect of the company's investor narrative, translating complex clinical, regulatory, and commercial developments into a compelling story. Reporting to the Chief Financial Officer, this leader will partner closely with the CEO and senior leadership team to shape market perception, drive investor confidence, and support long-term shareholder value creation. What you'll achieve - - Develop and execute a best-in-class investor relations strategy aligned with corporate objectives - Serve as a spokesperson to investors, analysts, and the broader financial community - Advise executive leadership on market perception, valuation drivers, and investor sentiment - Partner with internal stakeholders to ensure consistent, compliant, and high-impact disclosures - Craft and continuously refine a compelling equity story that balances near-term commercial execution with long value creation - Translate complex MedTech/scientific concepts into clear, credible, and
---
TITLE: Senior Financial Analyst
EMPLOYER: Repay Holdings Corp
LOCATION: Atlanta Headquarters (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-20
APPLY_URL: https://repay.wd1.myworkdayjobs.com/REPAYCareers/job/Atlanta-Headquarters/Senior-Financial-Analyst_JR607
EXCERPT: Senior Financial Analyst Atlanta Headquarters posted: Posted 23 Days Ago
---
TITLE: Oncology Account Manager – Nashville
EMPLOYER: Syndax Pharmaceuticals Inc
LOCATION: New York, NY (unspecified)
SALARY: $215K-$230K
POSTED: 2026-05-28
K401_MATCH: yes (not source-backed)
APPLY_URL: https://syndax.com/join-us/careers/?gh_jid=6008393004
EXCERPT: Oncology Account Manager – Nashville New York, NY Syndax Pharmaceuticals is looking for an Oncology Account Manager - Nashville At Syndax, we are determined to realize a future in which people with cancer live longer and better than ever before. Syndax Pharmaceuticals is a commercial stage biopharmaceutical company developing an innovative pipeline of cancer therapies. PLEASE NOTE: Territory coverage includes all of Tennessee The Role: The Oncology Account Manager will serve as a critical member of the Customer Engagement Team and will have an exciting opportunity within Syndax to build on the momentum of the successful launches of our first two products. The OAM will be responsible for meeting sales targets and utilizing all available resources while tailoring them to meet the customers' needs through a deep understanding of their requirements. Behaviors that are critical for success in this role are collaboration, communication, planning, relationship building, and the ability to execute tactical initiatives and provide timely feedback. OAMs will report directly to the Regional Business Director. Key Responsibilities: The OAM will achieve territory sales by utilizing their experience too: - Holistically support and manage territory accounts by creating relationships with physicians, allied healthcare professionals (Advanced Practitioners, Nurses, Pharmacists), and business stakeholders (CFOs, Office Practice Managers, Billers, etc.) - Maintain a uniquely deep and nuanced understanding of territory, including Opinion Leaders (OL) and other influencers, treatment and utilization trends, payer and reimbursement dynamics, and competitive opportunities and challenges. - Analyze business performance: Create and execute a comprehensive territory plan. This includes
---
TITLE: 实习医药信息顾问
EMPLOYER: Roche Holding AG
LOCATION: Beijing, Beijing, China's Mainland (unspecified)
SALARY: Not disclosed
POSTED: 2026-04-15
APPLY_URL: https://roche.wd3.myworkdayjobs.com/roche-ext/job/Beijing/_202604-109512/apply
EXCERPT: 实习医药信息顾问 Beijing, Beijing, China's Mainland We are looking for an enthusiastic Intern Medical Information Consultant to join our team at Roche. This role involves assisting in medical communication, education activities, and market research. If you are a university student with a background in pharmaceuticals and strong communication skills, we want to hear from you!
---
TITLE: Senior Manager, Quality Control Data Analyst
EMPLOYER: Vaxcyte Inc
LOCATION: San Carlos, California, United States (unspecified)
SALARY: $166K-$194K
POSTED: 2026-03-18
K401_MATCH: yes (not source-backed)
APPLY_URL: https://boards.greenhouse.io/vaxcyte/jobs/5151345008?gh_jid=5151345008
EXCERPT: Senior Manager, Quality Control Data Analyst San Carlos, California, United States Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: Vaxcyte has an exciting opportunity for a Senior Manager, Quality Control Data Analyst to join our QC organization to act as a bridge between our technical QC Operations team and Business teams. This individual will be responsible for the collection, evaluation, interpretation, and visualization of complex datasets to provide actionable
---
TITLE: QA Lead
EMPLOYER: Roche Holding AG
LOCATION: Shanghai, Shanghai, China's Mainland (unspecified)
SALARY: Not disclosed
POSTED: 2026-02-27
APPLY_URL: https://roche.wd3.myworkdayjobs.com/roche-ext/job/Shanghai/QA-Lead_202602-105114/apply
EXCERPT: QA Lead Shanghai, Shanghai, China's Mainland Join our team as a QA Lead at Roche, where you will oversee batch documentation, ensure compliance with cGMP standards, and lead quality assurance initiatives. If you have a strong background in pharmaceutical quality assurance and leadership skills, we want to hear from you!
---
TITLE: Product Director, Compliance (Transaction Monitoring & Case Management)
EMPLOYER: OKX
LOCATION: Singapore, Singapore (unspecified)
SALARY: Not disclosed
POSTED: 2026-04-16
APPLY_URL: https://job-boards.greenhouse.io/okx/jobs/7702611003
EXCERPT: Product Director, Compliance (Transaction Monitoring & Case Management) Singapore, Singapore Who We Are At OKX, we believe that the future will be reshaped by crypto, and ultimately contribute to every individual's freedom. OKX is a leading crypto exchange, and the developer of OKX Wallet, giving millions access to crypto trading and decentralized crypto applications (dApps). OKX is also a trusted brand by hundreds of large institutions seeking access to crypto markets. We are safe and reliable, backed by our Proof of Reserves. Across our multiple offices globally, we are united by our core principles: We Before Me , Do the Right Thing , and Get Things Done . These shared values drive our culture, shape our processes, and foster a friendly, rewarding, and diverse environment for every OK-er. OKX is part of OKG, a group that brings the value of Blockchain to users around the world, through our leading products OKX, OKX Wallet, OKLink and more. About the Opportunity - Develop and implement compliance strategies and frameworks to ensure our products and services adhere to applicable laws, regulations, and industry standards, while balancing customer experience and business growth - Stay updated with relevant regulatory changes and monitor industry trends to anticipate compliance requirements and potential risks - Collaborate with cross-functional teams, including product development, legal, operations, and quality assurance, to integrate compliance considerations into product planning and development processes - Monitor and track compliance metrics and key performance indicators (KPIs) to measure the effectiveness of compliance product initiatives and identify
---
TITLE: Packaging Operator 包装操作工
EMPLOYER: Roche Holding AG
LOCATION: Shanghai, Shanghai, China's Mainland (unspecified)
SALARY: Not disclosed
POSTED: 2026-02-27
APPLY_URL: https://roche.wd3.myworkdayjobs.com/roche-ext/job/Shanghai/Packaging-Operator-_202602-104761/apply
EXCERPT: Packaging Operator 包装操作工 Shanghai, Shanghai, China's Mainland Join our team as a Packaging Operator at Roche, where you will play a crucial role in ensuring compliance with GMP standards and optimizing packaging processes. If you have experience in the pharmaceutical industry and a passion for quality, we want to hear from you!
---
TITLE: Vice President Quality Assurance
EMPLOYER: Olema Pharmaceuticals
LOCATION: Boston, Massachusetts (unspecified)
SALARY: $315K-$340K
POSTED: 2026-06-04
APPLY_URL: https://job-boards.greenhouse.io/olema/jobs/5977235004
EXCERPT: Vice President Quality Assurance Boston, Massachusetts Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monotherapy and in combination in ER+/HER2- metastatic breast cancer. Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with best-in-class potential. Our scientific breakthroughs are accelerated through the ways in which we fearlessly support, motivate, and challenge one another. At Olema, we know that when we put people first, our work becomes second to none. If you're ready to join us at the edge of something unstoppable, let's make a profound impact together for our patients, for your career, for what's beyond . You can view our latest corporate deck and other presentations here . About the Role >>> Vice President, Quality Assurance The Vice President, Quality Assurance serves as the senior leader accountable for defining and driving Olema's global quality strategy, systems, and governance across the full product lifecycle, including clinical development, manufacturing, pharmacovigilance, and commercial. This leader is the primary voice of Quality at the executive level and ensures a phase-appropriate, risk-based approach to quality that reflects the needs of oncology drug development, where patient safety, data integrity, and speed are critical. Operating with appropriate independence, this role partners cross-functionally and leads an established Quality leadership team across GCP, GMP, and GPV - aligning priorities, strengthening execution, and ensuring inspection readiness as Olema advances
---
TITLE: MSAT Qualification Lead
EMPLOYER: Roche Holding AG
LOCATION: Shanghai, Shanghai, China's Mainland (unspecified)
SALARY: Not disclosed
POSTED: 2025-09-25
APPLY_URL: https://roche.wd3.myworkdayjobs.com/roche-ext/job/Shanghai/MSAT-Qualification-Lead_202509-124323/apply
EXCERPT: MSAT Qualification Lead Shanghai, Shanghai, China's Mainland Are you experienced in MSAT operations and looking to lead qualification efforts in a dynamic environment? Join Roche as an MSAT Qualification Lead, where you will drive strategic projects, mentor teams, and ensure compliance in the pharmaceutical industry.
---
TITLE: Director, Stability Management, Analytical Development and Quality Control
EMPLOYER: Revolution Medicines
LOCATION: Redwood City, California, United States (unspecified)
SALARY: $211K-$264K
POSTED: 2026-04-23
K401_MATCH: yes (not source-backed)
APPLY_URL: https://www.revmed.com/careers-list/?gh_jid=7712471003
EXCERPT: Director, Stability Management, Analytical Development and Quality Control Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Playing a critical role as the stability program lead, the position will be responsible for oversight and management of outsourced stability studies conducted. The director, stability is a self-motivated individual who works as a member of an integrated team contracting, designing, managing, and evaluating stability studies at contractors for both drug substance and drug product. This individual should have the breadth of experience required to manage stability studies in commercial, late and early clinical development stage. This individual should have broad knowledge of ICH and cGMP guidelines and the ability to contribute to global regulatory filings for stability. - Develop and implement the strategic direction of stability programs in alignment with ICH guidelines and regulatory expectations. - Oversee the design, execution, and management of stability studies (development, registration and commercial). - Work cross functionally with CMC, quality, regulatory, clinical
---
TITLE: Sr. Financial Analyst
EMPLOYER: Grocery Outlet Holding Corp
LOCATION: Emeryville Corp Hybrid (hybrid)
SALARY: Not disclosed
POSTED: 2026-04-30
APPLY_URL: https://recruiting.ultipro.com/GRO1006/JobBoard/4c6ab91f-73c0-bb4f-ad81-094171fac4c7/OpportunityDetail?opportunityId=1256b5ec-13a4-447c-8967-35a486008467
EXCERPT: Sr. Financial Analyst Emeryville Corp Hybrid As part of the Financial Planning & Analysis team, this person will be a key contributor to financial performance management activities including financial planning, reporting, and forecasting etc. They will collaborate with multiple stakeholders including accounting, business teams, as well as support the CFO and Senior Executives. The role reports into Manager of Finance, and work closely with other members of Finance team.
---
TITLE: Vice President, Manufacturing Operations & Managing Director
EMPLOYER: Vaxcyte Inc
LOCATION: Visp, Valais, Switzerland (unspecified)
SALARY: Not disclosed
POSTED: 2026-04-17
K401_MATCH: yes (not source-backed)
APPLY_URL: https://boards.greenhouse.io/vaxcyte/jobs/5193056008?gh_jid=5193056008
EXCERPT: Vice President, Manufacturing Operations & Managing Director Visp, Valais, Switzerland Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: We are seeking an experienced and dynamic leader to join Vaxcyte as Vice President, Manufacturing Operations & Managing Director for Vaxcyte Switzerland GmbH. This role will lead a high-performing operations organization in Switzerland, supporting late-stage development, commercial readiness, and long-term growth. The role will oversee critical capital projects, scale clinical and
---
TITLE: Assistant Buyer- Deli
EMPLOYER: Grocery Outlet Holding Corp
LOCATION: Emeryville Corp Hybrid (hybrid)
SALARY: Not disclosed
POSTED: 2026-05-21
APPLY_URL: https://recruiting.ultipro.com/GRO1006/JobBoard/4c6ab91f-73c0-bb4f-ad81-094171fac4c7/OpportunityDetail?opportunityId=7e52eace-ebb8-4b87-9e1d-150e1fadd2c1
EXCERPT: Assistant Buyer- Deli Emeryville Corp Hybrid You will be a part of the World Class Purchasing Team. The focus of this role is to ensure 100% accuracy of the data entered into Grocery Outlet's systems so the company can leverage data to optimize business decisions. You will enter and monitor all data entered into our systems including but not limited to Item Information, Product Images, Purchase Order Creation and Master Vendor Files. This role reports to a Buyer on the team.
---
TITLE: Vice President, Head of Alliance Management and Program Management ~ Onsite
EMPLOYER: Nurix Therapeutics Inc
LOCATION: Brisbane, CA (onsite)
SALARY: Not disclosed
POSTED: 2026-05-07
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/nurix/jobs/8540264002
EXCERPT: Vice President, Head of Alliance Management and Program Management ~ Onsite Brisbane, CA Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases. Powered by a fully AI-integrated discovery engine capable of tackling any protein class, and coupled with unparalleled ligase expertise, Nurix's dedicated team has built a formidable advantage in translating the science of targeted protein degradation into clinical advancements. Nurix aims to establish degrader-based treatments at the forefront of patient care, writing medicine's next chapter with a new script to outmatch disease. Vice President, Head of Alliance Management and Program Management Nurix Therapeutics is seeking an accomplished and strategic Vice President, Head of Alliance Management and Program Management to lead both our external collaborations with pharmaceutical partners and the internal coordination of our late stage hematology/oncology program. In addition to leading a high-impact alliance, this role will drive internal program management discipline, ensuring organizational awareness of program priorities, clear accountability for key workstreams, aligned roadmaps across functions, and transparent communication of status and risks to senior leadership. The ideal candidate is a dynamic leader who thrives in complexity, bridges science and business, and delivers executional excellence across partnerships and programs. Key Responsibilities - Alliance Leadership and Strategy - Serve as the primary point of contact between Nurix Therapeutics and its pharmaceutical partners, fostering a transparent, collaborative, and goal-oriented relationship.
---
TITLE: 大客户经理 - MCE
EMPLOYER: Roche Holding AG
LOCATION: Xian, Shaanxi, China's Mainland (unspecified)
SALARY: Not disclosed
POSTED: 2026-04-17
APPLY_URL: https://roche.wd3.myworkdayjobs.com/roche-ext/job/Xian/---MCE_202604-109472-1/apply
EXCERPT: 大客户经理 - MCE Xian, Shaanxi, China's Mainland We are looking for a Key Account Manager to manage commercial clients and develop regional hospital access plans. The ideal candidate will have over 5 years of experience in the pharmaceutical industry, strong project management skills, and excellent negotiation abilities.
---
TITLE: Associate Director, Process Validation and Risk Management
EMPLOYER: Vaxcyte Inc
LOCATION: San Carlos, California, United States (unspecified)
SALARY: $174K-$203K
POSTED: 2026-04-03
K401_MATCH: yes (not source-backed)
APPLY_URL: https://boards.greenhouse.io/vaxcyte/jobs/5173193008?gh_jid=5173193008
EXCERPT: Associate Director, Process Validation and Risk Management San Carlos, California, United States Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: The Associate Director, Process Validation and Risk Management will lead and facilitate commercial process validation and risk management activities across Vaxcyte's end-to-end manufacturing processes. This role focuses on technical strategy, execution, and cross-functional coordination to support commercial readiness, regulatory compliance, and lifecycle management. The incumbent will provide leadership to
---
TITLE: Regulatory Affairs Lead
EMPLOYER: Roche Holding AG
LOCATION: Subang Jaya, Selangor, Malaysia (unspecified)
SALARY: Not disclosed
POSTED: 2026-02-13
APPLY_URL: https://roche.wd3.myworkdayjobs.com/roche-ext/job/Subang-Jaya/Regulatory-Affairs-Lead_202601-100509-1/apply
EXCERPT: Regulatory Affairs Lead Subang Jaya, Selangor, Malaysia Join our team as a Regulatory Affairs Lead, where you will set strategies, manage regulatory compliance, and engage with health authorities to shape policies. If you have a strong background in regulatory affairs within the pharmaceutical industry, we want to hear from you!
---
TITLE: Vice President, Pharmaceutical Development
EMPLOYER: Kymera Therapeutics Inc
LOCATION: Watertown, MA (unspecified)
SALARY: $315K-$395K
POSTED: 2026-05-26
K401_MATCH: yes (not source-backed)
APPLY_URL: https://www.kymeratx.com/careers-culture/working-at-kymera/?gh_jid=7748334003#open-positions
EXCERPT: Vice President, Pharmaceutical Development Watertown, MA Who we are: Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients' lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston's top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X (formerly Twitter) or LinkedIn . How we work: - PIONEER : We are courageous, resilient and rigorous in our mission to improve patients' lives through our revolutionary degrader medicines. - COLLABORATE : We value trust + transparency from everyone. Our goals are shared, our decisions data-driven and our camaraderie genuine. - BELONG : We recognize our differences, inviting curiosity and inclusivity, so that our people are valued, seen, and heard. How you'll make an impact: - Define and lead the company's pharmaceutical development strategy across the portfolio, ensuring alignment with corporate priorities and development timelines - Provide strategic leadership for preformulation, biopharmaceutics, and formulation development activities supporting discovery, preclinical, and clinical-stage programs - Champion innovation in formulation sciences and enabling technologies to
---
TITLE: Business Partnership Leader
EMPLOYER: Roche Holding AG
LOCATION: Beijing, Beijing, China's Mainland (unspecified)
SALARY: Not disclosed
POSTED: 2026-04-18
APPLY_URL: https://roche.wd3.myworkdayjobs.com/roche-ext/job/Beijing/Business-Partnership-Leader_202603-106462/apply
EXCERPT: Business Partnership Leader Beijing, Beijing, China's Mainland Join our team as a Business Partnership Leader at Roche, where your expertise in sales strategy and channel management will drive our mission to innovate healthcare solutions. If you have a strong background in pharmaceutical sales and team leadership, we want to hear from you!
---
TITLE: Associate Director, Regulatory CMC
EMPLOYER: Vaxcyte Inc
LOCATION: San Carlos, California, United States (unspecified)
SALARY: $180K-$210K
POSTED: 2026-04-27
K401_MATCH: yes (not source-backed)
APPLY_URL: https://boards.greenhouse.io/vaxcyte/jobs/5196126008?gh_jid=5196126008
EXCERPT: Associate Director, Regulatory CMC San Carlos, California, United States Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: A hands-on role providing both strategic and operational activities. This role develops and executes multi-product global regulatory CMC strategies for investigational products and leads the preparation and filing of regulatory CMC submissions. Manages interactions with Health Authorities for CMC topics. Provides regulatory CMC guidance to various cross-functional teams and ensures all applicable
---
TITLE: QA Specialist, BIologics
EMPLOYER: Roche Holding AG
LOCATION: Shanghai, Shanghai, China's Mainland (unspecified)
SALARY: Not disclosed
POSTED: 2026-02-27
APPLY_URL: https://roche.wd3.myworkdayjobs.com/roche-ext/job/Shanghai/QA-Specialist--BIologics-_202602-105026/apply
EXCERPT: QA Specialist, BIologics Shanghai, Shanghai, China's Mainland Are you experienced in quality assurance within the pharmaceutical industry? Join our team as a QA Specialist in Biologics, where you will oversee quality operations, ensure compliance, and contribute to continuous improvement initiatives. Make a meaningful impact in healthcare with Roche!
---
TITLE: R0178927 Alternance - Contrôle Financier (H/F)
EMPLOYER: Takeda Pharmaceutical Company Limited
LOCATION: FRA - France - Paris (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-05
K401_MATCH: yes (not source-backed)
APPLY_URL: https://takeda.wd3.myworkdayjobs.com/External/job/FRA---France---Paris/R0178927-Alternance---Contrle-Financier--H-F-_R0181556
EXCERPT: R0178927 Alternance - Contrôle Financier (H/F) FRA - France - Paris posted: Posted 7 Days Ago
---

[PASTE YOUR RESUME OR SKILLS HERE]